Mattia Barbareschi
Mattia Barbareschi
S. Chiara Hospital, Trento, Italy
Email verificata su apss.tn.it
Titolo
Citata da
Citata da
Anno
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, ...
Journal of Clinical Oncology 12 (3), 454-466, 1994
5761994
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast
M Barbareschi, L Pecciarini, MG Cangi, E Macrì, A Rizzo, G Viale, ...
The American journal of surgical pathology 25 (8), 1054-1060, 2001
4462001
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
E Leonardi, S Girlando, G Serio, FA Mauri, G Perrone, S Scampini, ...
Journal of clinical pathology 45 (5), 416-419, 1992
2751992
High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi, P Maisonneuve, D Aldovini, MG Cangi, L Pecciarini, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
2522003
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
G Gasparini, M Barbareschi, C Doglioni, PD Palma, FA Mauri, P Boracchi, ...
Clinical cancer research 1 (2), 189-198, 1995
2361995
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs
M Barbareschi, B Murer, TV Colby, M Chilosi, E Macri, M Loda, C Doglioni
The American journal of surgical pathology 27 (2), 141-149, 2003
2102003
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ...
Clinical Cancer Research 13 (20), 6064-6069, 2007
2032007
AKT1 E17K in human solid tumours
FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ...
Oncogene 27 (42), 5648-5650, 2008
2012008
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
M Cigognetti, S Lonardi, S Fisogni, P Balzarini, V Pellegrini, A Tironi, ...
Modern Pathology 28 (8), 1043-1057, 2015
1872015
Prognostic value of p21 (WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
O Caffo, C Doglioni, S Veronese, M Bonzanini, A Marchetti, F Buttitta, ...
Clinical cancer research 2 (9), 1591-1599, 1996
1871996
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
A Marchetti, C Doglioni, M Barbareschi, F Buttitta, S Pellegrini, G Bertacca, ...
Oncogene 12 (6), 1319-1324, 1996
1741996
p53 and c-erb B-2 Protein Expression in Breast Carcinomas: An Immunohistochemical Study Including Correlations with Receptor Status, Proliferation Markers, and Clinical Stage …
M Barbareschi, E Leonardi, FA Mauri, G Serio, PD Palma
American journal of clinical pathology 98 (4), 408-418, 1992
1721992
The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status
C Doglioni, A Dei Tos, L Laurino, C Chiarelli, M Barbareschi, G Viale
Virchows Archiv 424 (1), 47-51, 1994
1601994
Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: a retrospective study of 103 cases with surgical correlation
L Righi, P Graziano, A Fornari, G Rossi, M Barbareschi, A Cavazza, ...
Cancer 117 (15), 3416-3423, 2011
1502011
mdm2 gene alterations and mdm2 protein expression in breast carcinomas
A Marchetti, F Buttitta, S Girlando, PD Palma, S Pellegrini, P Fina, ...
The Journal of pathology 175 (1), 31-38, 1995
1461995
p21 WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein …
M Barbareschi, O Caffo, C Doglioni, P Fina, A Marchetti, F Buttitta, R Leek, ...
British journal of cancer 74 (2), 208-215, 1996
1431996
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size
S Rossi, D Gasparotto, L Toffolatti, C Pastrello, G Gallina, A Marzotto, ...
The American journal of surgical pathology 34 (10), 1480-1491, 2010
1422010
Proliferating cell nuclear antigen expression in central nervous system neoplasms
A Allegranza, S Girlando, GL Arrigoni, S Veronese, FA Mauri, ...
Virchows Archiv A 419 (5), 417-423, 1991
1401991
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up
M Barbareschi, O Caffo, S Veronese, RD Leek, P Fina, S Fox, ...
Human pathology 27 (11), 1149-1155, 1996
1391996
ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach
G Pelosi, A Fabbri, F Bianchi, P Maisonneuve, G Rossi, M Barbareschi, ...
Journal of Thoracic Oncology 7 (2), 281-290, 2012
1332012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20